HIV Treatment Adherence Essay

Frankie Tilmon continues to be out of treatment compliance. Frankie has missed his last four appointments, 7/2/15, 7/9/15, 7/16/15, and 7/30/15. Frankie contacted this provider on 7/6 to apologize for missing his appointment on 7/2 and was reminded of his next appointment on 7/9, which he agreed to attend. On 7/15 Frankie contacted this provider to apologize for missing his treatment appointment on 7/9 and agreed to make his appointment the following day, which he failed to appear for. On 7/16 Frankie contacted this provider to again apologize for missing his appointment and wanted to confirm his next scheduled appointment day/time. I told Frankie that his appointment day and time has not changed; it was on Thursdays at 4pm. Frankie told

I would design a HIV Prevention Program for African American woman in college to decrease the growing rate of new HIV diagnoses each year and help women that are prone to HIV to decrease their risk behaviors in acquiring this virus. I will use the Social Cognitive Theory that focuses on the change of an individual and how individuals learn by using personal experiences.

Another recommended is to document that all risks associated with non-adherence to care plans were discussed as well as alternative treatment options were reviewed and that the patient verbalized understanding ( CMPA,

There is some good news in the fight against HIV. Between 2005 and 2014 new diagnosis of HIV have fallen by 19% nationwide (CDC, 2017). Those living with HIV are now living longer, healthier lives and have the opportunity to

It would be unfair for patients to miss out on life saving treatments because of the high cost of treatment. Additionally,

The data suggested that people 65 years old and older were more adherent with their ART prescription in comparison to their younger counterparts and managed to suppress their viral load. To further add the data also stated that male to male sexual contact had the highest rate of new diagnosis in 2011. However, as the continuum of care progressed the number of men engaged in treatment decreased by nearly 50% and hence reducing the chances of nearly half of newly diagnosed men adhering to the task of acquiring a suppressed viral load. The authors research stated that “of 15,449 people newly diagnosed with HIV in the 19

Due to the emphasis on these three measures supporting the HIV Care Continuum, grantees have seen results with over half of the reported data 80% or above. Among these three measures, 24 out of 38 grantees reported data above 90% for prescribing ART to patients. While a similar number of grantees reported data for these three measures, more grantees were successful in prescribing ART compared to viral

In the 1980s, the incidence of acquired immunodeficiency (AIDS) cases caused by the human immunodeficiency virus (HIV) rose to epidemic proportions in the US LGBT community predominantly due to their manifestation as Kaposi’s Sarcoma (KS), a viral mediated cancer (Haverkos & Curran, 1982). A major outcome out of the research on HIV-AIDS is the finding that the virus caused massive systemic immune suppression in the infected individuals, which in turn caused the patients to succumb to either opportunistic infections such as KS (Haverkos & Curran, 1982). However, HIV-induced KS also highlighted the dominant role of the human immune system to seek and destroy any cancer that could have been formed otherwise. It also implicated that there

“Human immunodeficiency virus (HIV) is a blood-borne virus typically transmitted via sexual intercourse, shared intravenous drug paraphernalia, and mother-to-child transmission (MTCT), which can occur during the birth processor during breastfeeding.” There is no cure for HIV or AIDS but over time different types of medications have been developed that slows down the advancement of the disease. AIDS is a lethal disease that is caused by HIV. HIV destroys the immune system and causes the body to not be able to fight off any diseases.

Although the introduction of highly active antiretroviral therapies (HAART) marked a seminal development in HIV-1 treatment, the therapies have since been characterized by poor patient adherence, a high incidence of acquired antiretroviral resistance in HIV-1, as well as endocrine and metabolic imbalances resulting in irregular fat redistribution (lipodystrophy), insulin resistance, and abnormal blood glucose (dysglycemia), cholesterol and lipids (dyslipidemia), and bone resorption and deposition.8 Atazanavir has

HIV is the human immunodeficiency virus that causes AIDS. A member of a group of viruses called retroviruses, HIV infects human cells and uses the energy and nutrients provided by those cells to grow and reproduce. AIDS (acquired immunodeficiency syndrome) is a disease in which the body's immune system breaks down and is unable to fight off certain infections, known as "opportunistic infections," and other illnesses that take advantage of a weakened immune system. When a person is infected with HIV, the virus enters the body and lives and multiplies primarily in the white blood cells. These are the immune cells that normally protect us from disease.

HIV, or the Human Immunodeficiency Virus, is a virus which damages and kills cells of the immune system. It attacks the T-cells, key cells of the immune system, and uses them to make copies of itself. After being infected with the virus it progressively interferes and eventually destroys the immune system's ability to fight the anti-genes. HIV may develop into the syndrome AIDS, the Acquired Immunodeficiency Syndrome. HIV is an STD - a sexually transmitted disease - and therefore most commonly it is spread through sexual contact, and the virus mainly enters the body through the penis, mouth, lining of the vagina or vulva during sexual activity. HIV can also be spread through sharing syringes or needles with someone who is infected with the

HIV becomes drug resistance when the ARV treatments’ are not adhered to. Once the patient has taken their antiretroviral (ARVs) medication then stops the HIV is able to replicate and will do so at a rapid rate. As a result mutations are very common (Jen Gorgan and Ruth Suter;2009)

Since its first discovery in 1981, HIV/AIDS has killed more than 25 million people worldwide and is today the major threat to human health. However, due to the introduction of highly active antiretroviral therapy (HAART) as well as the impact of preventive measures, the prevalence and incidence of HIV have declined globally over the last decade except for parts of Eastern Europe and Central Asia where a slight increase has been observed (UNAIDS, 2010; Cohen, 2012; Futterman, 2012; Kumari and Singh, 2012; Saxena et al., 2012). Even though HAART provides stable viral suppression, it is not devoid of undesirable side effects, especially in persons undergoing long-term treatment. The present therapy finds its limitations in the emergence of

The theories, interventions and strategies currently used to treat individuals diagnosed with HIV/AIDS involve several factors as it relates to a chronic disease. According to Auslander & Freedenthal in Gehlert & Browne (2012), HIV/AIDS is a chronic disease that once diagnosed, requires adherence to complex and challenging treatment regimens. Prevention of this disease requires changes in behavior that would lead to the reduction of less risky sexual behaviors. Harm reduction is a particular treatment approach that is used with HIV/AIDS individuals. As stated by Straussner (2014), Harm reduction treatment is both a philosophy and treatment approach. It was adapted in the United States in the 1980’s to minimize the transmission of HIV among injection drug users. Clean needles were distributed to injection drug users to reduce the spread of HIV/AIDS